Ulrike Dirmeier
Impact in
- Virology top 10%
- Immunology top 10%
- interferon and immune responses
- Immunotherapy and Immune Responses
Papers in
-
- Immunotherapy and Immune Responses 4
- Oncology 6
- Viral-associated cancers and disorders 3
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Wolfgang Hammerschmidt (3 shared papers)Ellen Kilger (2 shared papers)Falk Nimmerjahn (2 shared papers)Diana Dudziak (2 shared papers)Georg W. Bornkamm (2 shared papers)Mark L. Sandberg (1 shared paper)G. Reisbach (1 shared paper)Bernhard Neuhierl (1 shared paper)
- Journals
- Journal of Virology (3 papers)Clinical Cancer Research (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Oncotarget (1 paper)PLoS ONE (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Ulrike Dirmeier
14 papers receiving 815 citations
Peers
Comparison fields: 5 of 73
- Virology 70
- Immunology 299
- Oncology 291
- Cancer Research 128
- Pathology and Forensic Medicine 105
Countries citing papers authored by Ulrike Dirmeier
This map shows the geographic impact of Ulrike Dirmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Dirmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Dirmeier more than expected).
Fields of papers citing papers by Ulrike Dirmeier
This network shows the impact of papers produced by Ulrike Dirmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Dirmeier. The network helps show where Ulrike Dirmeier may publish in the future.
Co-authors
The 25 scholars most cited alongside Ulrike Dirmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 186 | |
| 2 | 2011 | 133 | |
| 3 | 2005 | 117 | |
| 4 | Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus. | 2003 | 116 |
| 5 | 2017 | 51 | |
| 6 | 2010 | 42 | |
| 7 | 2003 | 41 | |
| 8 | 2000 | 38 | |
| 9 | 2015 | 26 | |
| 10 | 2013 | 24 | |
| 11 | 2011 | 22 | |
| 12 | 2018 | 21 | |
| 13 | 2017 | 19 | |
| 14 | 2015 | 3 |
About Ulrike Dirmeier
Ulrike Dirmeier is a scholar working on Immunology, Oncology, Epidemiology, Genetics and Infectious Diseases, having authored 14 papers that have together received 839 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Virus-based gene therapy research (4 papers), Viral-associated cancers and disorders (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Poxvirus research and outbreaks (2 papers), Hepatitis B Virus Studies (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Viral Infections and Outbreaks Research (2 papers). The work is most often cited by research in Virology (70 citations), Immunology (299 citations), Oncology (291 citations), Cancer Research (128 citations) and Pathology and Forensic Medicine (105 citations). Ulrike Dirmeier has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Wolfgang Hammerschmidt, Ellen Kilger, Falk Nimmerjahn, Diana Dudziak, Georg W. Bornkamm, Mark L. Sandberg, G. Reisbach, Bernhard Neuhierl, Louis M. Staudt and Josef Mautner. Their work appears in journals such as Journal of Virology, Clinical Cancer Research, Journal for ImmunoTherapy of Cancer, Oncotarget and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.